MENU
GLMD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Galmed Pharmaceuticals (GLMD) Earnings Date & Reports

Galmed Pharmaceuticals Ltd is a biopharmaceutical company... Show more

A.I. Advisor
published Earnings

GLMD is expected to report earnings to rise 25.40% to -79 cents per share on November 10

Galmed Pharmaceuticals GLMD Stock Earnings Reports
Q3'25
Est.
$-0.79
Q2'25
Beat
by $0.20
Q3'23
Beat
by $0.03
Q2'23
Est.
$-0.34
Q1'23
Beat
by $0.41
The last earnings report on August 28 showed earnings per share of -62 cents, beating the estimate of -82 cents. With 85.42K shares outstanding, the current market capitalization sits at 6.96M.
View a ticker or compare two or three
GLMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. GLMD showed earnings on August 28, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a manufacturer of pharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
16 Tiomkin Street
Phone
+972 36938448
Employees
10
Web
https://www.galmedpharma.com